iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Earnings for iRhythm Technologies, Inc. (IRTC)
Earnings in 2023 (TTM): $-122,656,000
According to iRhythm Technologies, Inc.'s latest financial reports the company's current earnings (TTM) are $-122,656,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of iRhythm Technologies, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-122,656,000 | $-123,406,000 |
| 2022 | $-115,886,000 | $-116,155,000 |
| 2021 | $-100,994,000 | $-101,361,000 |
| 2020 | $-43,601,000 | $-43,830,000 |
| 2019 | $-54,503,000 | $-54,568,000 |
| 2018 | $-48,236,000 | $-48,280,000 |
| 2017 | $-29,420,000 | $-29,420,000 |
| 2016 | $-20,903,000 | $-20,903,000 |
| 2015 | $-22,799,000 | $-22,799,000 |
| 2014 | $-15,832,000 | $-15,832,000 |
| 2013 | $-13,589,000 | $-13,589,000 |